OLIGOMERIX INC has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ICHAN SCHOOL OF MEDICINE AT MOUNT SINAI, GLIMCHER LAURIE H and US OF AMERICA AS REPRESENTED B.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Machines | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Heterocyclic compounds | |
#7 | Measuring microorganism processes | |
#8 | Unspecified technologies | |
#9 | Animal care | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Moe James G | 16 |
#2 | Davidowitz Eliot J | 14 |
#3 | Gluchowski Charles | 7 |
#4 | Hendrix James | 7 |
#5 | Bian Haiyan | 7 |
#6 | Yehaskel Albert S | 5 |
#7 | Reitz Allen B | 5 |
#8 | Mcdonnell Mark E | 5 |
#9 | Loughran Marie H | 4 |
#10 | Grossman Abraham | 4 |
Publication | Filing date | Title |
---|---|---|
US2019345115A1 | Novel quinazolinones that inhibit the formation of tau oligomers and their method of use | |
EP3562483A2 | Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use | |
WO2012162179A1 | Tau protease compositions and methods of use | |
WO2012054008A2 | Methods and compositions comprising tau oligomers | |
US2008220449A1 | Biomarkers and assays for Alzheimer's disease | |
US2007218491A1 | Oligomerization of amyloid proteins | |
WO2007126473A2 | Oligomerization of amyloid proteins | |
US2006024697A1 | Compositions and methods for binding agglomeration proteins |